Website Index


Home

Directory of 1,000 Healthcare Recruiters  physician recruiters

Health Administration Toolbox 

 

Calendar of Health Observance Dates

Recommended

 

Reading Lists & Healthcare Bookstore New!

 

Job Search Resources  

 

Career & Interview Resources 

 

Glossary of Managed Care Terms 

 

Health Care Companies & Hospitals 

 

Health & Medical Associations 

 

Tools for Physician Executives 

 

Tools for Finance Directors 

 

Tools for Nursing Managers 

 

Tools for Personnel Managers 

 

Tools for Traveling Executives 

 

Search this Site


About Us

About Pam Pohly Associates

Info for Healthcare Employers 

Info for Job Hunters

Jobs to Apply for  

Our Hot Jobs 

Pam Pohly's Background

Contact Us

 


If you are interested in policy or books about health care reform, please see our up-to-date collection here: Politics, Policy & Reform.

 


 

 

To search this site, click here

Copyright© Pam Pohly, All Rights Reserved.  

Return Home



You are here > Home > Reading Lists > Directories, Data & Benchmarks > Health Care Industry Almanac

 

Plunkett's Biotech and Genetics Industry Almanac

 

2011 Book & CD Edition
Softbound, 600+ pages + bonus CD-ROM
Size: 8.5" x 11"
ISBN 1593921799
978-1593921798
Plunkett Research
October 2010
(click below for the best currently available price for this important resource)

Plunkett's Biotech & Genetics Industry Almanac is a complete reference guide to the business side of biotechnology, genetics, proteomics and related services.

 

This new book contains complete profiles of the leading biotech companies, in-depth chapters on trends in genetics, technologies, statistics and finances, a handy glossary and thorough indexes. For the first time, in one carefully-researched volume, you'll get all of the data you need. Topics include:

  • A Short History of Biotechnology;

  • The State of the Biotechnology Industry Today;

  • Biotechnology funding and investments;

  • Patents;

  • Biotech activities in Singapore and China;

  • FDA;

  • Gene Therapies;

  • Personalized Medicine;

  • Systems Biology;

  • Drug Development;

  • Clinical Trials;

  • Controversy over Drug Prices;

  • Stem Cells Research;

  • Therapeutic Cloning;

  • Regenerative Medicine Nanotechnology;

  • Agricultural Biotechnology;

  • Drug Delivery Systems;

  • BioShield;

  • Ethical Issues.

The book also includes complete profiles on over 400 Biotech & Genetics companies, our own unique list of companies that are the leaders in biotechnology. These are the largest, most successful corporations in all facets of this exploding business.

 

All of the corporate profile information is indexed and cross-indexed, including contact names, addresses, Internet addresses, fax numbers, toll-free numbers, plus growth and hiring plans, finances, research, marketing, technology, acquisitions and much more for each firm. Fully covered are these topics:

  • Major Trends Affecting the Biotech & Genetics Industry

    • The State of the Biotechnology Industry Today

    • A Short History of Biotechnology

    • Ethanol Production Soared, But a Market Glut May Slow Expansion

    • New Money Pours into Biotech Firms/Mergers and Acquisitions Surge Ahead

    • Major Drug Companies Bet on Partnerships With Smaller Biotech Research Firms

    • From India to Singapore to Australia, Nations Compete Fiercely in Biotech Development

    • Gene Therapies and Patients' Genetic Profiles Promise a Personalized Approach to Medicine

    • New Kinase Inhibitors Are Breakthrough Drugs for Cancer Treatment-Many More Will Follow

    • Few New Blockbusters: Major Drug Patents Expire While Generic Sales Soar

    • Biotech and Orphan Drugs Pick Up the Slack as Blockbuster Mainstream Drugs Age

    • Biogenerics (Follow-on Biologics) are in Limbo in the U.S.

    • Breakthrough Drug Delivery Systems Evolve

    • Stem Cells-Controversy in the U.S. Threatens to Leave America Far Behind in the Research Race

    • Stem Cell Funding Trickles in the U.S. at the Federal Level While a Few States Create Funding of Their Own

    • Stem Cells-Therapeutic Cloning Techniques Advance

    • Stem Cells-A New Era of Regenerative Medicine Looms

    • Nanotechnology Converges with Biotech

    • Agricultural Biotechnology Scores Breakthroughs but Causes Controversy/Selective Breeding Offers a Compromise

    • Focus on Vaccines

    • Ethical Issues Abound

    • Technology Discussion-Genomics

    • Technology Discussion-Proteomics

    • Technology Discussion-Microarrays

    • Technology Discussion-DNA Chips

    • Technology Discussion-SNPs ("Snips")

    • Technology Discussion-Combinatorial Chemistry

    • Technology Discussion-Synthetic Biology

    • Technology Discussion-Recombinant DNA

    • Technology Discussion-Polymerase Chain Reaction (PCR)

  • Biotech & Genetics Industry Statistics

    • Biotech Industry Overview

    • Global Biotechnology at a Glance

    • Growth in Global Biotechnology

    • 20 Largest Global Pharmaceutical Companies

    • Global Area of Biotech Crops by Country

    • Biotechnology Financing, U.S., Europe & Canada

    • U.S. Biotechnology at a Glance

    • Quarterly Breakdown of Biotechnology Financings, U.S. & Canada

    • Ernst & Young Survival Index, U.S. & Canadian Biotechnology Companies

    • Domestic & Foreign Pharmaceutical Sales, PhRMA Member Companies

    • Sales by Geographic Area, PhRMA Member Companies

    • Domestic Biopharmaceutical R&D & R&D Abroad, PhRMA Member Companies

    • Domestic Biopharmaceutical R&D Breakdown, PhRMA Member Companies

    • R&D By Global Geographic Area, PhRMA Member Companies

    • Biologics & Biotechnology R&D, PhRMA Member Companies

    • R&D as a Percentage of U.S. Biopharmaceutical Sales, PhRMA Member Companies

    • U.S. Exports & Imports of Pharmaceutical Products

    • Summary of Value of U.S. Shipments of Pharmaceutical Preparations, Except Biologicals

    • Value of U.S. Shipments of Pharmaceutical Preparations, Except Biologicals, Detailed

    • Federal R&D & R&D Plant Funding for General Science & Basic Research, U.S.

    • Research Funding for Biological Sciences, U.S. National Science Foundation: Fiscal Years

    • National Health Expenditure Amounts by Type of Expenditure, U.S

    • Prescription Drug Expenditures, U.S.

    • U.S. Prescription Drug Expenditures, Aggregate & Per Capita Amounts, Percent Distribution

    • The U.S. Drug Discovery & Approval Process

    • U.S. FDA Approval Times for New Drugs

    • U.S. FDA Approval Times for New Molecular Entities (NMEs)

    • U.S. Pharmaceutical R&D Spending Versus the Number of New Molecular Entity (NME) Approvals

    • Total U.S. Biotechnology Patents Granted per Year by Patent Class

    • Plant-Derived Pharmaceuticals for the Treatment of Human Diseases that are in the Pipeline for Commercialization

    • Employment in Life & Physical Science Occupations by Business Type, U.S.

    • Domestic Biopharmaceutical R&D Scientific, Professional & Technical Personnel by Function, PhRMA Member Companies

    • Important Biotech & Genetics Industry Contacts
      (Addresses, Phone Numbers and Internet Sites)

  • THE BIOTECH

    • Who They Are and How They Were Chosen

    • Industry List, With Codes

    • Index of Rankings Within Industry Groups

    • Alphabetical Index

    • Index of Headquarters Location by U.S. State

    • Index of Non-U.S. Headquarters Location by Country

    • Index by Regions of the U.S. Where the Firms Have Locations

    • Index by Firms with Operations Outside the U.S.

    • Individual Profiles on Each of THE BIOTECH 400

  • Additional Indexes

    • Index of Hot Spots for Advancement for Women/Minorities

    • Index by Subsidiaries, Brand Names and Selected Affiliations

Purchasers of either the book or PDF version can request a free copy of the company profiles database on CD-ROM, enabling export of contact names, addresses and more.

 

Plunkett Research, Ltd. is a leading provider of industry sector analysis and research, industry trends and industry statistics. Plunkett's client list includes 5,000 leading corporations, universities and government agencies worldwide. Their research reports are used by the world’s top corporations, consultants, universities, libraries and government agencies. Plunkett Research, Ltd. was established in 1985. Plunkett is frequently interviewed as an expert source by publications such as Newsweek, The Wall Street Journal, The New York Times and Investor's Business Daily, media outlets such as NPR's Marketplace, ABC, and CBS Marketwatch, as well as local and regional newspapers and national columnists. Plunkett’s products save time and effort when you need competitive intelligence, market research, vertical industry marketing data, or industry trends analysis.

 

You may also be interested in / The Directory of Healthcare Recruiters /

 

Jump to a List / Health Administration & Leadership / Physician Executive, Medical Staff & Practice Management / Finance, Accounting, Economics, Billing & Reimbursement / Coding for Hospital, Physician & Clinical Services / Law, Malpractice, Ethics, Accreditation & Compliance / Quality Improvement, Outcomes & Customer Service / Risk Management, Security, Error Reduction & Patient Safety / Information Systems, Technology & Medical Records / Clinical Management & Executive Nursing / Behavioral Health, Social Work & Psychiatry Management / Human Resources, Management & Supervision / Directories, Data, Trends & Benchmarks / Software & CD-ROMs / Gift Ideas & Recommended Gifts / Journals, Magazines & Newsletters / Search for Books / Books Index /

 

Go Back to Pages / Home Page / Toolbox for Health Administrators / Bookstore /